Experience with prostate-specific antigen in prostatic carcinoma

Research output: Contribution to journalArticle

1 Citation (Scopus)


A total of 71 prostatic tumour patients and 45 prostatic adenoma patients were tested for prostate-specific antigen (PSA), immunological prostatic acid phosphatase (PAP) concentration as well as serum prostatic phosphatase (SPP) and enzymic serum phosphatase. It was found among untreated patients that PSA showed the highest percentage of pathologic affection in each stage. PSA, on the evidence of clearance test in the initial days of therapy and after a follow-up period of several months, gave a good picture of the course that the disease had taken.

Original languageEnglish
Pages (from-to)465-472
Number of pages8
JournalInternational urology and nephrology
Issue number5
Publication statusPublished - Sep 1 1991

ASJC Scopus subject areas

  • Nephrology
  • Urology

Fingerprint Dive into the research topics of 'Experience with prostate-specific antigen in prostatic carcinoma'. Together they form a unique fingerprint.

  • Cite this